Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$13,500,000
Company Info
- Founders
- Anat Burkovitz
- Company Description
- A pre-clinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of difficult-to-treat cancers. TrojanBio is a pharmaceutical company that develops therapeutic antibody solutions related to anti-viral immunity and various cancer types.
- Market
- Healthcare & Wellness
- Coinvestors
- NFX
Links